ClinicalTrials.gg
RecruitingNCT07547943TMH-USGUpdated Nov 13, 2026

TMH And Ultrasound For Difficult Airway Prediction

An observational study in Difficult Airway and Airway Management, sponsored by Bursa City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Bursa City Hospital · Observational

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Updated Nov 13, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
240
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational study aims to evaluate the predictive value of thyromental height (TMH) and ultrasonographic airway measurements in predicting difficult airway in adult patients undergoing elective surgery under general anesthesia.

Preoperative airway assessment will include standard clinical evaluation, TMH measurement, and ultrasonographic measurements of anterior neck soft tissue. Perioperative airway management data, including intubation difficulty, number of attempts, and Cormack-Lehane classification, will be recorded.

The relationship between preoperative measurements and difficult airway will be analyzed to determine their predictive accuracy and clinical usefulness.

Read the detailed description

Difficult airway management remains a critical issue in anesthetic practice, associated with significant morbidity and mortality. Traditional clinical airway assessment methods have limited sensitivity and specificity in predicting difficult airway. Recently, thyromental height (TMH) and ultrasonographic airway measurements have been proposed as promising tools for improving prediction accuracy.

This prospective, single-center observational study will be conducted in adult patients undergoing elective surgery under general anesthesia. Patients aged 18 years and older with ASA physical status I-III will be included.

Preoperative evaluation will include standard airway assessment methods such as Mallampati score, mouth opening, sternomental distance, and thyromental distance. In addition, TMH will be measured, and ultrasonographic measurements of anterior neck soft tissues will be performed, including skin-to-epiglottis distance, pretracheal soft tissue thickness, and hyomental distance.

Perioperative airway management data will be recorded, including Cormack-Lehane classification, number of intubation attempts, use of adjunct airway devices, and intubation difficulty score.

The primary objective is to evaluate the predictive value of TMH and ultrasonographic measurements for difficult airway. Secondary objectives include assessing their relationship with intubation difficulty, number of attempts, and airway-related complications.

The findings of this study are expected to contribute to improved preoperative airway assessment and safer airway management strategies in clinical practice.

02

Conditions studied

  • Difficult Airway
  • Airway Management

Keywords

  • Thyromental Height
  • Airway Ultrasound
  • Difficult Intubation
  • Cormack-Lehane
03

In context

Lead sponsor

Bursa City Hospital is the lead sponsor of 71 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing elective surgical procedures under general anesthesia at a tertiary care hospital will be prospectively enrolled. All participants will undergo standardized preoperative airway assessment, including thyromental height measurement and ultrasonographic airway evaluation, followed by perioperative airway management assessment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adult patients aged 18 years and older

Patients scheduled for elective surgery under general anesthesia

Patients requiring endotracheal intubation

Patients who provide written

Exclusion criteria

Exclusion Criteria:

Patients with known upper airway pathology (e.g., tumor, trauma, infection)

Patients with previous head and neck surgery or anatomical deformity affecting airway evaluation

Patients with limited mouth opening (\<3 cm) or severe cervical spine restriction

Patients with to ultrasonographic examination

Patients requiring rapid sequence induction or emergency surgery

Patients who refuse to participate

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
240 participants (estimated)
Patient registry
No

Groups and cohorts

  • Airway Assessment Cohort

    Adult patients undergoing elective surgery under general anesthesia will be included. All participants will undergo standard preoperative airway assessment, including thyromental height (TMH) measurement and ultrasonographic airway evaluation. Intraoperative airway management and intubation-related parameters will be recorded to assess the predictive value of TMH and ultrasound measurements for difficult airway.

06

What researchers measure

Primary outcomes

  1. Prediction of Difficult Intubation

    The primary outcome is the ability of thyromental height (TMH) and ultrasonographic airway measurements to predict difficult intubation. Difficult intubation will be defined as Cormack-Lehane grade ≥3, requirement of multiple intubation attempts, or use of advanced airway devices.

    Time frame: During induction of anesthesia (intraoperative period)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to institutional policies and protection of patient confidentiality.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for May 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2026
First posted
Apr 23, 2026
StartActual
May 16, 2026
Primary completionEst.
May 15, 2027
CompletionEst.
May 15, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 13, 2026
Sites
Bursa City Hospital is now Recruiting
Nov 13, 2026
Start date
May 15, 2026→May 16, 2026 (actual)
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Not yet recruiting→Recruiting
    Bursa City Hospital is now Recruiting
    Start date May 15, 2026→May 16, 2026 (now actual)
    + 3 other changes: verification date, responsible party and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07547943
Lead sponsor
Bursa City Hospital
Collaborators
Ulusoy, Emre, M.D.
Responsible party
Serra Topal (Assistant Professor of Anesthesiology, Bursa City Hospital) — Principal investigator
First posted
Apr 23, 2026
Start date
May 16, 2026
Primary completion
May 15, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Serra Topal, MD
Contact
dr.serra@msn.com
05068823855

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion